Skip to main content
. 2020 Nov;8(22):1514. doi: 10.21037/atm-20-7041

Table 2. Baseline clinical characteristics of patients with different renal function (CKD stage 1 and CKD stage 2).

Characteristics (n=943) CKD stage 1 CKD stage 2
Hypertension (n=284) Non-hypertension (n=233) P value Hypertension (n=282) Non-hypertension (n=144) P value
Age (year) 58.80±8.25 58.36±7.59 NS 66.49±8.37 66.18±9.39 NS
eCCr (mL/min/1.73 m2) 99.61±7.37 99.74±6.75 NS 77.18±8.29 77.74±8.35 NS
cTnT (ng/mL) 0.10±0.13 0.10±0.13 NS 0.019±0.47 0.018±0.42 NS
NT-proBNP (ng/L) 227.50±551.11 276.35±531.94 NS 722.25±1,647.55 721.97±1,279.43 NS
LAD (mm) 39.75±4.96 38.27±5.41 <0.01 41.42±6.36 39.97±6.80 <0.05
LADi (cm/m2) 2.53±0.33 2.45±0.36 <0.01 2.65±0.41 2.56±0.44 <0.05
LVEDd (mm) 48.17±5.97 47.58±6.01 NS 49.11±8.16 47.88±8.37 NS
LVESd (mm) 31.45±6.39 30.82±6.19 NS 32.76±8.63 32.32±9.13 NS
IVST (mm) 9.93±1.55 9.30±1.72 <0.01 10.34±2.02 9.67±1.98 <0.01
LVPWT (mm) 9.48±1.08 9.06±1.11 <0.01 9.70±1.30 9.25±1.17 <0.01
PASP (mmHg) 32.76±5.50 33.22±7.72 NS 35.46±9.07 35.37±10.26 NS
LVEF (%) 63.35±8.14 64.21±8.03 NS 61.05±10.11 60.52±11.18 NS
E/A ratio <1 (n/valuable, %) 165/264 (62.5) 116/215 (54.0) NS 187/252 (74.2) 79/119 (66.4) NS
LVM (g) 167.50±48.00 152.41±46.36 <0.01 181.85±64.86 162.67±66.48 <0.01
LVMi (g/m2) 106.42±29.12 97.30±29.00 <0.01 115.73±39.35 103.74±41.26 <0.01

CKD, chronic kidney disease; eCCr, endogenous creatinine clearance rate; NT-proBNP, N terminal pro B type natriuretic peptide; cTnT, Cardiac troponin T; LAD, left atrial diameter; LADi, left atrial diameter index; LVEDd, left ventricular end-diastolic diameter; LVESd, left ventricular end-systolic diameter; IVST, interventricular septal thickness; LVPWT, left ventricular posterior wall thickness; PASP, pulmonary artery systolic pressure; LVEF, left ventricular ejection fraction; LVM, left ventricular mass; LVMi, left ventricular mass index.